3rd Circ. Urged Not To Halt Antitrust Suit Over GSK Drug
A pair of drug wholesalers on Friday pressed the Third Circuit not to stay an appeal of their antitrust class action over a generic-drug deal between GlaxoSmithKline LLC and Teva Pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article